Ken-ichi Hanada, M.D., Ph.D.
- Center for Cancer Research
- National Cancer Institute
- Building 10, Room 3w-3840
- Bethesda, MD 20892-1201
- 240-858-3774
- hanadak@mail.nih.gov
RESEARCH SUMMARY
Dr. Hanada received M.D. degree at Tokyo Medical and Dental University and a Ph.D. at the University of Tokyo, Japan. He joined the Surgery Branch, NCI in 1997 as a visiting scientist and became a staff scientist in 2005. He has been involved in the basic studies of immune response to renal cell carcinoma and also in the development of clinical trials for renal cell carcinoma.
Areas of Expertise
Ken-ichi Hanada, M.D., Ph.D.
Publications
Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytes
aß T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities
Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinoma
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
Double or nothing on cancer immunotherapy
Biography
Ken-ichi Hanada, M.D., Ph.D.
Dr. Hanada received M.D. degree at Tokyo Medical and Dental University and a Ph.D. at the University of Tokyo, Japan. He joined the Surgery Branch, NCI in 1997 as a visiting scientist and became a staff scientist in 2005. He has been involved in the basic studies of immune response to renal cell carcinoma and also in the development of clinical trials for renal cell carcinoma.